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Abstract
Background: Previous studies have shown that adequate thickness or initial augmentation of soft tissue has a
positive effect on the stability of peri-implant bone. This randomized, controlled trial aimed to evaluate the
influence of augmenting soft tissue with platelet-rich fibrin (PRF) on crestal bone and soft tissue around implants.
Methods: After randomization, 31 fully threaded titanium implants were inserted in 31 patients (16 men and
15 women) in the lower mandible using a split-flap technique. In the test group (10 patients), mucosa was
treated with a PRF membrane. In the control group (21 patients), implantation was realized without soft tissue
augmentation. Tissue thickness was measured at point of implant insertion (baseline) and at time of reentry after
3 months. Standardized digital radiographs were obtained for evaluation at time of implant placement, reentry after
3 months and at a 6-month follow-up. Data was analyzed by an independent examiner.
Results: After 6 months, all 31 implants were osteointegrated. Soft tissue augmentation with PRF led to a
significant tissue loss. In the test group, the crestal tissue thickness dropped from 2.20 mm ± 0.48 SD at baseline to
0.9 mm ± 1.02 SD at reentry, whereas crestal mucosa in the control group showed higher stability (2.64 mm± 0.48
SD at baseline to 2.62 mm± 0.61 SD at reentry). For ethical reasons, the test group was terminated after 10 cases,
and the remaining cases were finished within the control group. In the test group, radiographic evaluation showed
a mean bone loss of 0.77 mm ± 0.42 SD/0.57 mm ± 0.44 SD (defect depth/defect width) on the mesial side and
0.82 mm ± 0.42 SD/0.62 mm ± 0.36 SD (defect depth/defect width) on the distal side. In the control group, a mean
bone loss of 0.72 mm ± 0.61 SD/0.51 mm ± 0.48 mm (defect depth/defect width) on the mesial and 0.82 mm ± 0.77
SD/ 0.57 mm ± 0.58 SD (defect depth /defect width) on the distal side was measured.
Conclusions: Within the limits of this study and the early determination of the test group, this study concludes
that soft tissue augmentation with PRF performed with a split-flap technique cannot be recommended for
thickening thin mucosa. Further studies focusing on different techniques and longer follow-ups are needed to
evaluate whether PRF is suitable for soft tissue thickening.
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Background
The initial bone modeling around implants within the
first year after insertion presents a challenging topic in
current research. Previous studies have shown that this
process is characterized by a remodeling of the horizon-
tal and vertical bone dimension with a range of 0.7 to
3 mm within the first year [1].
First attempts to reduce this loss of tissue focused on
changes of implant shapes, implant surfaces, implant
position, and abutment design. The concept of “platform
switching” seemed to be the most promising step in this
process. Hürzeler et al. and Vela-Nebot et al. reported a
reduced loss of bone substance with platform-switched
abutments when compared to regular abutments after a
6-month loading. Cochran et al. and Canullo et al. sup-
port this thesis, whereas Becker et al. could not report
any histological differences between platform-switched
and regular abutments [2–6]. However, initial bone
modeling could not be fully avoided in the abovemen-
tioned studies.
A second approach to reduce bone loss is the altering
of peri-implant soft tissue. Berglundh et al. showed that
the peri-implant mucosa has many features in common
with the gingiva around natural teeth [7]. Around im-
plants, a biological constant is formed comparable to the
biological width, characterized by a thick epithelial layer
of 2 mm and a suprabony connective tissue layer of
1 mm. Abrahamsson published similar results, showing
that the dentogingival complex around implants ranges
from 3.5 mm to 4 mm [8]. Lindhe et al. reported that
thinning or destruction of this tissue thickness leads in-
evitably to peri-implant bone resorption [9]. This implies
that the existence of a minimum of peri-implant mucosa
thickness is crucial for the long-term stability of the
bone level.
Linkevicius et al. showed that the initial tissue
thickness influences crestal bone changes around im-
plants [10, 11]. After 6 months, the group of patients
with thin tissue (up to 2 mm) had a mean bone loss
of 1.35 mm+/−0.33 SD, whereas patients with normal
tissue or thick tissue (3.1 mm and more) showed sig-
nificantly less bone loss (0.32 mm+/−0.44 SD and
0.12 mm+/−0.52 SD, respectively) [10].
As a consequence, recent research focused on soft tis-
sue augmentation of thin gingiva types prior to or simul-
taneous to implant insertion. Wiesner et al. published a
significant gain of soft tissue by thickening the gingiva
with a connective soft tissue graft harvested from the
palate [12]. Soft tissues at augmented sites were 1.3 mm
thicker than on control sites and had a better pink es-
thetic score. However, this technically sensitive proced-
ure did not lead to less peri-implant bone loss (0.8 mm
in the grafted group, 0.6 mm in the non-grafted group
after 1-year loading).
Lai et al. and Linkevicius et al. reported a successful ver-
tical augmentation of soft tissue by using an acellular der-
mal matrix membrane [13, 14]. Furthermore, Linkevicius
showed that thickening with an allogenic membrane re-
sulted in significantly reduced initial bone loss (0.21-mm
bone loss in the augmented group, 1.17-mm bone loss in
the control group after 1-year follow-up) [14].
Another attempt to influence the peri-implant
bone structures is the use of platelet-rich fibrin
(PRF). This second-generation platelet concentrate
described by Choukroun et al. is a fibrin matrix
enriched with cytokines, circulating progenitor cells,
and growth factors which can be used as a resorba-
ble membrane in surgery. Studies show a constant
release of growth factors such as PDGF (platelet-de-
rived growth factor) or TGF-b (transforming growth
factor) for at least 1 week [15, 16] up to 28 days
[17] and proved its accelerating effect on the healing
process. The application of PRF has been tested in
various disciplines of dentistry so far. However, no
data of vertical soft tissue augmentation with PRF
has yet been published.
The aim of this randomized, controlled clinical trial
was to evaluate whether the use of PRF is suitable for
soft tissue thickening of the peri-implant mucosa and to
assess the marginal bone level changes.
Methods
Patient selection
Patients aged 18+ who required an implant in the pos-
terior mandible were eligible for this study.
Exclusion criteria were the following:
– general contraindications to implant surgery
– insufficient oral hygiene and periodontitis
– patients with a history of severe periodontitis




– severe cardiovascular problems
– treated or under treatment with intravenous amino-
bisphosphonates
– pregnant or lactating.
The study was conducted in accordance with the stan-
dards of the Declaration of Helsinki of 1983 and was ap-
proved by the ethics committee of the FEKI (Freiburger
Ethik-Kommission International, Feki Code: 014/1210).
All 40 recruited patients were informed about the design
and aim of this study, and written consent was obtained.
The randomization to control group (n = 20) and test
group (n = 20) was achieved using a sealed envelope sys-
tem at time of surgery.
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Clinical procedure
All patients had to undergo a professional dental hygiene
treatment in advance. One hour prior to surgery, pa-
tients were given an antibiotic single shot prophylaxis
(600 mg clindamycin). PRF was obtained from each pa-
tient of test and control groups and treated according to
the PRF protocol with an IntraSpin™ table centrifuge and
collection kits provided by Botiss (Zossen, Germany).
After anesthesia with Ultracain® DS-forte (articaine +
adrenaline 1:100,000), crestal, lingual, and buccal tissue
thickness was tested using an endodontic micro-spreader
(Spreader ISO 30, Dentsply Maillefer®) with a silicon stop
(illustration 1). The instrument part penetrating the soft
tissue was measured with an endodontic longimeter. Mea-
sured data was rounded off to the nearest half millimeter
(mm).
The initial preparation of the split-flap was carried out
the same way in test and control groups using microsur-
gical instruments. After a crestal incision with a micro-
surgical blade (SM69, Swann Morton LTD®, Sheffield,
England), the split-thickness flap was sharply prepared
by elevating the area of the single tooth gap to the mid-
dle of the adjacent teeth. The periosteum was split to re-
ceive a tension-free adaption of the flaps (illustration 2).
Fully threaded titanium implants (Nobel Speedy Re-
place®, Nobel Biocare, Zurich, Switzerland) were inserted
at bone level with primary stability. The implants varied
in diameter (narrow platform 3.5 mm, regular platform
4.0 mm, wide platform 5.0 mm) and in length (10 mm,
11.5 mm, 13 mm) (illustrations 3, 4, and 5). For the
further procedure, patients were now randomized by a
dental assistant using a sealed envelope system. In the test
group, the tissue was augmented with a PRF membrane
using a double-layered technique. In the control group,
the implant treatment was realized without mucosa thick-
ening (illustrations 6 and 7). Flaps were sutured with a
non-absorbable polyvinylidene fluoride suture (Seralene®,
Serag Wiessner, Naila, Germany) (illustration 8).
After the implantation, standardized digital X-rays were
taken with parallel technique (baseline) (illustration 9).
For each patient, an individual customized digital film
Illustration 3 Insertion of the implant
Illustration 1 Measurement of tissue thickness with an
endodontic micro-opener
Illustration 2 Crestal incision and preparation of a split-flap
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holder was fabricated to ensure a reproducible radio-
graphic analysis. Patients were instructed to avoid chewing
hard nutrition in the treated area and to use chlorhexidine
mouthwash and a soft brush twice a day for the first
2 weeks. Sutures were removed after 7 to 10 days.
Three months later, a second measurement of crestal,
buccal, and lingual tissue thickness and intraoral radio-
graphs were carried out as mentioned above. A small
mid-crestal incision was made and cover screws were re-
placed by healing abutments. Due to the minimal inva-
sive reentry procedure, no sutures were needed. Within
the following 2 weeks, one-piece, screwed, full ceramic
crowns were inserted as definite restorations (IPS Emax®,
Ivoclar Vivadent, Schaan, Liechtenstein; composite: Mul-
tilink Implant®, Ivoclar Vivadent, Schaan, Liechtenstein)
(illustration 10). In a 6-month follow-up from baseline,
patients were recalled for maintenance and another
digital X-ray was taken.
Radiographic assessments
The evaluation of the peri-implant bone remodeling was
carried out by an independent examiner, who was not
involved in the surgical process. Bone loss at the mesial
and distal side of each implant was measured with an
image analysis software (Kodak dental imaging software,
version 6.13.0, 2013). A calibration of length measure-
ment was performed in every radiograph to avoid
Illustration 4 NobelSpeedy Replace®
(source: https://www.nobelbiocare.com/de/de/home/products-and-
solutions/implant-systems/nobelspeedy.html)
Illustration 5 Implant placed with a split-flap technique
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radiographic distortion (reference value - implant length
and width).
Statistical analysis
Data of 31 patients (10 patients of test group and 21 pa-
tients of control group) were analyzed with STATIS-
TICA (version 9.1, StatSoft, Inc., Tulsa, USA) and BiAS
(version 10.11, Epsilon, Frankfurt, Germany). No data
points were missing.
The analysis focused on the following aspects:
– Comparison of tissue thickness (crestal, buccal,
lingual) at baseline and 3-month data in test and
control groups
– Comparison of tissue gain/loss between test and
control groups
Illustration 6 PRF membrane made by centrifugating and pressing the patient’s blood
Illustration 7 Insertion of PRF membranes in a double-layered
technique for tissue augmentation Illustration 8 Fixation of the flap with Seralene® 6.0
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– Comparison of mesial and distal bone level at
baseline, 3-month and 6-month data in test and
control groups
– Comparison of bone level alterations between test
and control groups.
Data were expressed as means ± standard deviation.
Comparisons were made using the Wilcoxon test, the
Mann–Whitney U test, and the multiple comparisons
test by Schaich-Hamerle (p = 0.05).
Results
At time of surgery, the patients ranged in age from 33 to
79 years (mean age 53.8 years).
The first surgeries for implant placement in the test
group were carried out as described above. Two layers
of a PRF matrix were placed on top of the implant.
Though surgical flaps were all sutured completely free of
tension, a post-operative dehiscence above the implant
could be observed in all test patients within the first
week. This process resulted in a complete loss of mucosal
and augmented tissues above the implant. The open areas
were healed by secondary intention (illustration 11). The
wounds in the control group healed uneventfully by pri-
mary intention; no dehiscences occurred.
Due to ethical reasons, the test group had to be termi-
nated after 10 patients. The already recruited, remaining
patients were consequently all added to the control
group. Finally, the study was finished with a total num-
ber of 31 consecutive patients (16 males and 15 females,
10 patients in the test group, 21 in the control group).
No drop-out occurred within the 6 months. All im-
plants were clinically osseointegrated and stable and
showed no sign of infection.
Mucosa thickness
Crestal mucosa thickness in test group dropped from
2.20 mm ± 0.48 SD at baseline to 0.90 mm ± 1.02 SD
at reentry. This loss was statistically significant. Buc-
cal mucosa thickness was 1.85 mm ± 0.41 SD at base-
line and 2.15 mm ± 0.78 SD at 3-month follow-up,
and lingual thickness started from 1.55 mm ± 0.44 SD
and resulted in 1.80 mm ± 0.63 SD. Buccal and lingual
data did not reach statistical significance. Within the
Illustration 9 a–c Radiographic control a at time of implant placement (a), 3 months post-operative (b), and 6 months post-operative (c)
Illustration 10 a–d Second measuring, reentry, and insertion of a screwed, full ceramic crown
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limited data provided by the early termination of the
study, it can be stated that PRF under the condition
of a split-flap design failed to improve the thickness
of the mucosa.
In the control group, crestal mucosa thickness de-
creased from 2.64 mm± 0.48 SD at baseline to 2.62 mm±
0.61 SD at 3-month follow-up. Buccal and lingual mucosa
was 2.29 mm± 0.54 SD resp. 1.62 mm± 0.55 SD at base-
line and dropped to 2.36 mm± 0.48 SD resp. 1.86 mm±
0.53 SD. The differences of all three measuring points
were not statistically significant (Figs. 1 and 2).
Marginal bone level
The mean marginal bone level alterations are displayed
in Fig. 3.
Six months after surgery, both groups showed a statis-
tically significant peri-implant bone loss.
Radiographic evaluation of bone level in the test group
The mesial resp. distal defect depth was 0.70 mm± 0.72
SD resp. 0.64 mm± 0.66 SD at baseline. Six months later,
the marginal bone defect increased to 1.47 mm± 0.65 SD
on the mesial side resp. 1.46 mm± 0.54 SD on the distal
side. The corresponding defect width changed from
0.7 mm± 0.72 SD to 1.22 mm± 0.57 SD (mesially) and
from 0.65 mm± 0.64 SD to 1.27 mm± 0.55 SD (distally).
Radiographic evaluation of bone level in the control group
In the control group, defect depth changed from
0.13 mm ± 0.26 SD to 0.86 mm ± 0.52 SD (mesially) and
from 0.2 mm ± 0.37 SD to 1.02 mm± 0.62 SD (distally).
Defect width increased from 0.09 mm ± 0.17 SD to
0.60 mm ± 0.47 SD (mesially) and from 0.24 mm ± 0.42
SD to 0.81 mm ± 0.44 SD (distally).
Comparison of differences in bone loss between test and
control groups
The test group showed a mean bone loss of 0.77 mm ±
0.42 SD/0.57 mm ± 0.44 SD (defect depth/defect width)
on the mesial side and 0.82 mm ± 0.42 SD/0.62 mm ±
0.36 SD (defect depth/defect width) on the distal side.
Illustration 11 a–d Post-operative healing process at 3 days post-operative (a), 1 week post-operative (b), 1 month post-operative (c), and
3 months post-operative (d)
Fig. 1 Control group (no PRF augmentation) Fig. 2 Test group (PRF augmentation)
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In the control group, a mean bone loss of 0.72 mm ±
0.61 SD/0.51 mm ± 0.48 mm (defect depth/defect width)
on the mesial side and 0.82 mm ± 0.77 SD/0.57 mm ±
0.58 SD (defect depth/defect width) on the distal side
was measured.
However, the comparison of the differences in bone
loss showed no significance between the control and test
groups (all p > 0.05, Mann–Whitney U test).
Discussion
In this study over a period of 6 months, it could be dem-
onstrated that mucosal tissue thickening above implants
with PRF led to reduced tissue thickness when per-
formed in a split-flap technique.
The initial post-operative dehiscence and the asso-
ciated complete loss of mucosal and augmented
tissue above the implant were observed in all test
patients.
PRF is supposed to be a good healing aid in various as-
pects of dentistry [18]. Choukron and his associates in-
troduced this technique to implant dentistry to improve
bone healing [15]. According to his studies, the natural
fibrin framework protects growth factors from proteoly-
sis, so they can stay active for a longer period (up to
28 days [17]). This leads to an effective neovasculariza-
tion and an accelerated wound closing with less post-
operative infections [16, 19]. Though PRF has been
tested successfully in surgical procedures with reference
to hard tissue augmentation (sinus lift, socket preserva-
tion) [20, 21] and in the field of periodontal regeneration
[22], publications of PRF usage in combination with soft
tissue augmentation are rare and allow no real conclu-
sion so far.
The first assumption that comes up is whether the
higher tension on the flaps caused by the additional vol-
ume of the PRF membranes was adequately compen-
sated. This can be clearly affirmed. Split flaps were
expanded widely until the middle of the adjacent teeth.
In addition to that, a very sensitive suture material was
used to secure an adaption completely free of tension (il-
lustration 8). The essential point that needs to be critic-
ally reviewed in this study is the insertion of PRF in
combination with a split-flap technique. The bilayered
insertion of PRF allows a better nutrition of the augmen-
tation material itself and avoids higher peri-implant bone
loss due to trauma and infection of the periosteum [22].
However, this highly technique-sensitive procedure re-
quires much experience. Moreover, the initial thin mu-
cosa is split into two extremely thin layers. A sufficient
nutrition of the flap requires a minimum flap thickness
of 0.8–1.2 mm [23, 24]. Since the blood supply of these
flaps with reduced thickness cannot be provided only
from the lateral, additional nutrition from the perios-
teum and the bone is necessary to maintain a livid flap.
This may explain the punctual dehiscence above the im-
plant itself, which occurred in all 10 test patients. Ac-
cording to the authors’ observations during this study,
the nutrition problem coming up with the split-flap
technique seems to be the crucial factor for the poor re-
sults with reference to soft tissue thickening.
Fig. 3 Peri-implant bone level at baseline, 3 months post-operative, and 6 months post-operative. a Mesial defect depth. b Mesial defect width.
c Distal defect depth. d Distal defect width
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With respect to marginal bone loss, it could be shown
that there were no significant differences when compar-
ing dimension of bone loss between test and control
groups. The study of present research data shows, to the
best knowledge of the authors, no other RCTs about tis-
sue thickening with PRF and peri-implant bone loss.
However, several studies focused on mucosa thickening
with tissue grafts and assessed the marginal bone loss
around implants. Hehn et al. and Wiesner et al. achieved a
stable mucosa thickening by augmenting the initial situ-
ation with a tissue graft taken from the palate [12, 25].
Whereas Hehn could show a reduced bone loss after
12 months, Wiesner’s results show no difference in bone
loss between test and control sides.
A second technique is the use of membranes. Lai et al.
postulated a successful, long-term stable augmentation
by using an acellular dermal matrix (ADM group in-
creased by 3.10+/−0.64 mm at 12 weeks, control group
increased by 0.30+/−0.50 mm) [13]. Puisys et al. focusing
on the coherence of membrane tissue augmentation and
peri-implant bone loss show similar results. They came
to the conclusion that initial soft tissue augmentation
with an allogenic collagen matrix resulted in a long-term
stable thickened mucosa. Furthermore, the bone loss
around implants was significantly less when implants
were placed in naturally thick tissue than in thin tissue.
Bone loss 1 year after surgery around implants with a
thin mucosa was 1.22+/−0.08 mm bone loss mesially
and 1.14+/−0.07 mm distally. Around implants placed
in a thick mucosa, it was 0.24+/−0.06 mm mesially
and 0.19+/−0.06 mm distally. The attempt to thicken
thin mucosa with an allogenic membrane resulted in
highly reduced bone loss (0.22+/−0.06 mm mesially
and 0.20+/−0.06 mm distally after 1 year) [11].
One limitation of this study is the standardized radio-
graphic evaluation. This technique allows information
about the peri-implant bone only on the mesial and dis-
tal but not on the buccal and lingual side. However, this
fact is limiting most present studies focusing on the
peri-implant bone level [5, 26]. Yet, the main limitation
of this study is the small number of patients. For this
reason, these findings cannot be generalized to soft tis-
sue augmentation with PRF on this study alone.
Conclusions
Soft tissue augmentation with PRF using a split-flap
technique cannot be recommended to alter thin gingiva
types. Future experimental and clinical studies will be
necessary to evaluate whether augmentation with PRF is
suitable for mucosa thickening.
Abbreviations
PDGF: platelet-derived growth factor; PRF: platelet-rich fibrin; SD: standard
deviation; TGF-b: transforming growth factor-b.
Competing interests
Julia Hehn, Thomas Schwenk, Marcus Striegel, and Markus Schlee declare
that they have no competing interests. This study was self-supported.
Authors’ contributions
JH was responsible for the study design and recruitment of the patients,
carried out the implant surgery and follow-up examinations, and drafted
the manuscript. TS participated in the surgical treatment and follow-up
examinations. MS performed the digital measurements. MS conceived
the study, participated in its design and coordination, and reviewed the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
The authors thank Dr. Wolfgang Reimers of MedCommTools for performing
the statistics.
Author details
1Periodontology, Edel & Weiß Clinic, Ludwigsplatz 1a, 90403 Nuremberg,
Germany. 2Esthetic Dentistry, Edel & Weiß Clinic, Nuremberg, Germany.
3Private Clinic for Periodontology, Forchheim and Department of
Maxillofacial Surgery, Goethe University, Frankfurt, Germany.
Received: 30 July 2015 Accepted: 23 March 2016
References
1. Cardaropoli G et al. Tissue alterations at implant-supported single-tooth
replacements: a 1-year prospective clinical study. Clin Oral Implants Res.
2006;17(2):165–71.
2. Fickl S et al. Dimensional changes of the alveolar ridge contour
after different socket preservation techniques. J Clin Periodontol.
2008;35(10):906–13.
3. Vela-Nebot X et al. Benefits of an implant platform modification technique
to reduce crestal bone resorption. Implant Dent. 2006;15(3):313–20.
4. Cochran DL et al. Consensus statements and recommended clinical
procedures regarding risk factors in implant therapy. Int J Oral Maxillofac
Implants. 2009;24(Suppl):86–9.
5. Canullo L et al. Platform switching and marginal bone-level alterations:
the results of a randomized-controlled trial. Clin Oral Implants Res.
2010;21(1):115–21.
6. Becker J et al. Influence of platform switching on crestal bone changes at
non-submerged titanium implants: a histomorphometrical study in
dogs. J Clin Periodontol. 2007;34(12):1089–96.
7. Berglundh T et al. The soft tissue barrier at implants and teeth. Clin Oral
Implants Res. 1991;2(2):81–90.
8. Abrahamsson I et al. The peri-implant hard and soft tissues at different
implant systems. A comparative study in the dog. Clin Oral Implants Res.
1996;7(3):212–9.
9. Berglundh T, Lindhe J. Dimension of the periimplant mucosa. Biological
width revisited. J Clin Periodontol. 1996;23(10):971–3.
10. Linkevicius T et al. Reaction of crestal bone around implants depending on
mucosal tissue thickness. A 1-year prospective clinical study. Stomatologija.
2009;11(3):83–91.
11. Puisys A, Linkevicius T. The influence of mucosal tissue thickening on crestal
bone stability around bone-level implants. A prospective controlled clinical
trial. Clin Oral Implants Res. 2015;26(2):123–9.
12. Wiesner G et al. Connective tissue grafts for thickening peri-implant tissues
at implant placement. One-year results from an explanatory split-mouth
randomised controlled clinical trial. Eur J Oral Implantol. 2010;3(1):27–35.
13. Lai HC et al. Buccal soft tissue augmentation using acellular dermal matrix
in implant therapy. Zhonghua Kou Qiang Yi Xue Za Zhi. 2006;41(7):395–6.
14. Linkevicius T, et al. Influence of vertical soft tissue thickness on crestal bone
changes around implants with platform switching: a comparative clinical
study. Clin Implant Dent Relat Res. 2015;17(6):1228–36.
15. Dohan DM et al. Platelet-rich fibrin (PRF): a second-generation platelet
concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 2006;101(3):e45–50.
16. Choukroun J, et al. Platelet-rich fibrin (PRF): a second-generation platelet
concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 2006;101(3):e56–60.
Hehn et al. International Journal of Implant Dentistry  (2016) 2:13 Page 9 of 10
17. He L et al. A comparative study of platelet-rich fibrin (PRF) and platelet-rich
plasma (PRP) on the effect of proliferation and differentiation of rat
osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2009;108(5):707–13.
18. Naik B et al. Role of Platelet rich fibrin in wound healing: a critical review.
J Conserv Dent. 2013;16(4):284–93.
19. Dohan DM et al. Platelet-rich fibrin (PRF): a second-generation platelet
concentrate. Part III: leucocyte activation: a new feature for platelet
concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2006;101(3):e51–5.
20. Ali S, et al. Platelet-rich fibrin in maxillary sinus augmentation: a systematic
review. J Oral Implantol. 2015;41(6):746–53.
21. Baslarli O et al. Evaluation of osteoblastic activity in extraction sockets
treated with platelet-rich fibrin. Med Oral Patol Oral Cir Bucal.
2015;20(1):e111–6.
22. Mounir M et al. Assessment of marginal bone loss using full thickness
versus partial thickness flaps for alveolar ridge splitting and immediate
implant placement in the anterior maxilla. Int J Oral Maxillofac Surg.
2014;43(11):1373–80.
23. Rebele SF et al. Tunnel technique with connective tissue graft versus
coronally advanced flap with enamel matrix derivative for root coverage: a
RCT using 3D digital measuring methods. Part II. Volumetric studies
on healing dynamics and gingival dimensions. J Clin Periodontol.
2014;41(6):593–603.
24. Zuhr O et al. Tunnel technique with connective tissue graft versus coronally
advanced flap with enamel matrix derivative for root coverage: a RCT using
3D digital measuring methods. Part I. Clinical and patient-centred
outcomes. J Clin Periodontol. 2014;41(6):582–92.
25. Hehn A, Schlee M. Does thickening of the mucosa avoid the initial bone
resorption around implants? A clinical, prospective, randomized, controlled
trial. Lucerne: Poster-Competition, 4th Camlog Congress; 2012.
26. Abrahamsson I, Berglundh T. Effects of different implant surfaces and
designs on marginal bone-level alterations: a review. Clin Oral Implants Res.
2009;20 Suppl 4:207–15.
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Hehn et al. International Journal of Implant Dentistry  (2016) 2:13 Page 10 of 10
